196 related articles for article (PubMed ID: 21165166)
1. On the crossroad between tolerance and posttransplant lymphoma.
Nalesnik MA; Starzl TE
Curr Opin Organ Transplant; 1997 Oct; 2(1):30-35. PubMed ID: 21165166
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
3. Salvage Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplant With Posttransplant Cyclophosphamide for Graft Failure in a Patient With Chronic Active Epstein-Barr Virus Infection.
Nakaya Y; Koh H; Harada N; Okamura H; Misugi T; Suekane T; Tachibana D; Kimura H; Hino M; Nakamae H
Exp Clin Transplant; 2023 Feb; 21(2):184-188. PubMed ID: 36919727
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD.Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2012 Apr; 10(2):141-7. PubMed ID: 22432758
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: new insights through latent membrane protein 1 fingerprinting.
Schäfer H; Berger C; Aepinus C; Hebart H; Beck R; Kaiserling E; Kanz L; Einsele H; Knecht H
Transplantation; 2001 Aug; 72(3):492-6. PubMed ID: 11502981
[TBL] [Abstract][Full Text] [Related]
6. Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
Kołodziejczak M; Gil L; de la Camara R; Styczyński J;
Ann Hematol; 2021 Mar; 100(3):763-777. PubMed ID: 33491135
[TBL] [Abstract][Full Text] [Related]
7. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients.
Reinsmoen NL; Jackson A; McSherry C; Ninova D; Wiesner RH; Kondo M; Krom RA; Hertz MI; Bolman RM; Matas AJ
Transplantation; 1995 Dec; 60(12):1546-54. PubMed ID: 8545888
[TBL] [Abstract][Full Text] [Related]
8. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant Lymphoproliferative Disorder Manifesting as Intestinal Epstein-Barr Virus-Positive Anaplastic Large-Cell Lymphoma in an Adult Renal Transplant Recipient.
Börcek P; Özdemir BH; Özgün G; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):64-66. PubMed ID: 27805515
[TBL] [Abstract][Full Text] [Related]
10. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic engraftment and graft failure after bone marrow transplantation.
Quinones RR
Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):3-17. PubMed ID: 8095382
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
Uhlin M; Wikell H; Sundin M; Blennow O; Maeurer M; Ringden O; Winiarski J; Ljungman P; Remberger M; Mattsson J
Haematologica; 2014 Feb; 99(2):346-52. PubMed ID: 24056821
[TBL] [Abstract][Full Text] [Related]
13. Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma.
Maloney DG
Leuk Lymphoma; 2003; 44 Suppl 3():S99-105. PubMed ID: 15202532
[TBL] [Abstract][Full Text] [Related]
14. New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells.
Waller EK; Boyer M
Bone Marrow Transplant; 2000 May; 25 Suppl 2():S20-4. PubMed ID: 10933181
[TBL] [Abstract][Full Text] [Related]
15. Immunodeficiency-associated lymphomas.
Tran H; Nourse J; Hall S; Green M; Griffiths L; Gandhi MK
Blood Rev; 2008 Sep; 22(5):261-81. PubMed ID: 18456377
[TBL] [Abstract][Full Text] [Related]
16. Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes.
Emanuel DJ; Lucas KG; Mallory GB; Edwards-Brown MK; Pollok KE; Conrad PD; Robertson KA; Smith FO
Transplantation; 1997 Jun; 63(11):1691-4. PubMed ID: 9197369
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease.
Aguayo-Hiraldo P; Arasaratnam R; Rouce RH
Bol Med Hosp Infant Mex; 2016; 73(1):31-40. PubMed ID: 29421230
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-associated lymphomas.
Shannon-Lowe C; Rickinson AB; Bell AI
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
